Difference between revisions of "Tau protein"
m |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
| − | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
| − | |||
| − | |||
|- | |- | ||
| Substrate peptide name | | Substrate peptide name | ||
| Line 8: | Line 6: | ||
|- | |- | ||
| Synonyms | | Synonyms | ||
| − | | - | + | | Microtubule-associated protein tau |
| + | Neurofibrillary tangle protein | ||
|- | |- | ||
| Determination type | | Determination type | ||
| Line 23: | Line 22: | ||
|- | |- | ||
| Reactive glutamines | | Reactive glutamines | ||
| − | | Q6, Q88, Q124, Q244, Q276, Q288, Q351, Q424 | + | | Q6, Q88, Q124, Q244, Q276, Q288, Q351, '''Q424''' |
|- | |- | ||
| Reactive lysines | | Reactive lysines | ||
| − | | K24, K163, K174, K180, K190, K225, K234, K240, K383, K385 | + | | K24, '''K163, K174, K180, K190, K225, K234, K240''', K383, K385 |
|- | |- | ||
| Substrate sequence | | Substrate sequence | ||
| − | | MAEPR''Q''EFEVM | + | | MAEPR''Q''EFEVM, GLGDR''K''DQGGY, |
| − | GLGDR''K''DQGGY | + | GAPGK''Q''AAAQP, |
| − | GAPGK''Q''AAAQP | + | AGHVT''Q''ARMVS, |
| − | AGHVT''Q''ARMVS | + | APPGQ''K''GQANA, |
| − | APPGQ''K''GQANA | + | TRIPA''K''TPPAP''K''TPPSS, |
| − | TRIPA''K''TPPAP''K''TPPSS | + | TREPK''K''VAVVR, |
| − | TREPK''K''VAVVR | + | AKSRL''Q''TAPVP, |
| − | AKSRL''Q''TAPVP | + | GGGKV''Q''IINKK, |
| − | GGGKV''Q''IINKK | + | DLSNV''Q''SKCGS, |
| − | DLSNV''Q''SKCGS | + | FKDRV''Q''SKIGS, |
| − | FKDRV''Q''SKIGS | + | FRENA''K''A''K''TDHGA, |
| − | FRENA''K''A''K''TDHGA | ||
MVDSP''Q''LATLA | MVDSP''Q''LATLA | ||
|- | |- | ||
| Line 47: | Line 45: | ||
|- | |- | ||
| Surface accessibility | | Surface accessibility | ||
| − | | | + | | |
|- | |- | ||
| Disorder prediction | | Disorder prediction | ||
| Line 53: | Line 51: | ||
|- | |- | ||
| Reference | | Reference | ||
| − | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids= | + | | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9832162&dopt=Abstract PMID:9832162] |
| + | [http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=11154823&dopt=Abstract PMID:11154823] | ||
|- | |- | ||
| Notes | | Notes | ||
| Line 60: | Line 59: | ||
Upon TG2 action the protein becomes less susceptible to μ-calpain mediated proteolysis. | Upon TG2 action the protein becomes less susceptible to μ-calpain mediated proteolysis. | ||
|- | |- | ||
| − | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase|*]] | [[Category:Tissue transglutaminase|*]] | ||
Latest revision as of 11:58, 10 March 2015
| Tau protein | |
|---|---|
| Substrate peptide name | Tau protein |
| Synonyms | Microtubule-associated protein tau
Neurofibrillary tangle protein |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Cytoskeleton |
| Swissprot ID | P10636 |
| Reactive glutamines | Q6, Q88, Q124, Q244, Q276, Q288, Q351, Q424 |
| Reactive lysines | K24, K163, K174, K180, K190, K225, K234, K240, K383, K385 |
| Substrate sequence | MAEPRQEFEVM, GLGDRKDQGGY,
GAPGKQAAAQP, AGHVTQARMVS, APPGQKGQANA, TRIPAKTPPAPKTPPSS, TREPKKVAVVR, AKSRLQTAPVP, GGGKVQIINKK, DLSNVQSKCGS, FKDRVQSKIGS, FRENAKAKTDHGA, MVDSPQLATLA |
| Structure | 1I8H |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:9832162 |
| Notes | Bold indicates the predominant substrate sites for TG2.
Upon TG2 action the protein becomes less susceptible to μ-calpain mediated proteolysis. |
